Tipizálási módszerek kidolgozása Candida fajok elkülönítésére by HASH(0x7fe95c4b7318)
UNIVERSITY OF SZEGED 
FACULTY OF INFORMATICS AND NATURAL SCIENCES 
DEPARTMENT OF MICROBIOLOGY 
 
 
NEW METHODS FOR BIOTYPING OF CANDIDA 
SPECIES 
 
PHD THESIS 
 
 
SUBMITTED BY: ZOLTÁN FARKAS 
 
SUPERVISOR: DR. ILONA PFEIFFER 
 
 
 
 
 
 
 
 
 
SZEGED 
2010 
 1
Introduction 
 
Infections caused by Candida species are widespread throughout the world. Among 
them, C. albicans is the most important species encountered as a cause of both superficial 
and systemic infections. C. albicans has been found to be responsible for about 45-60% 
of human infections, with one of the highest rate (77-80%) observed in Hungary. Clinical 
manifestations of C. albicans include superficial infections such as cutaneous candidiasis, 
oropharyngeal candidiasis, and vulvovaginitis that are frequent but usually benign in 
immuno-competent hosts. They are also able to cause severe infections including 
candidemia and disseminated candidiasis. 
Information on the genetic diversity of C. albicans population is important in 
order to adapt prevention policies. Several typing techniques, including random amplified 
polymorphic DNA (RAPD) analysis, CA3 fingerprinting, electrophoretic karyotyping 
and multilocus sequence typing (MLST) have been used for characterising C. albicans 
populations. The abovementioned methods employ nuclear markers. As an alternate, the 
analysis of the extrachromosomal mitochondrial DNA (mtDNA) of C. albicans is a 
successful tool to detect intraspecific genetic variability in this species. The mtDNA of C. 
albicans is circular, with the size of 40420 bp (SC 5314 strain, accession number: 
AF285261). It contains the standard set of mitochondrial genes. An existing mtDNA 
based method is the EO3 typing, since the EO3 region (within the duplicated region in its 
stem-and-loop structure) exhibits a DNA-size polymorphism 
Competition for territories and food in the nature had forced organisms to develop 
different mechanisms for their successful spreading and living. Among these are the 
antagonistic relationships, where a given organism represses the growth of its 
competitors. The antifungal property of killer toxins raises the possibility of many 
agricultural and industrial applications. Analysis of the sensitivity pattern of different 
yeast species against a killer toxin is a cheap typing method, but difficult to standardize 
it. Some Pichia strains have an outstanding antagonistic effect against several fungal 
species, including human pathogen yeasts. 
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Aims of the work: 
 
- study of mtDNA polymorphism of C. albicans clinical isolates and strains from 
culture collections 
- physical and partial functional mapping of the mtDNA types 
- establisment of new PCR RFLP based typing method 
- study of mtDNA polymorphism of C. parapsilosis clinical isolates 
- whole mitochondrial genome sequencing of Candida maltosa 
- comparative analysis of mitochondrial introns of the species belonging to C. 
albicans clade 
- characterization of an anti-Candida toxin produced by Pichia anomala VKM Y-
159 strain 
- identification of its biochemical properties, the cell wall receptor and reveal of its 
mode of action 
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Methods 
 
• Classical microbiological methods 
§ Maintenance of the strains 
§ Production of the toxins 
§ UV mutagenesis 
• Molecular methods 
§ Isolation of mitochondrial DNA 
§ mtDNA RFLP 
§ RFLP PCR 
§ Physical mapping 
§ Cloning 
§ Transformation 
§ Random sequencing 
§ PFGE (pulsed field gelelectrophoresis) 
• Protein based techniques 
§ SDS PAGE method 
§ Native PAGE method 
§ Ion-exchange chromatography 
§ Affinity chromatography 
• Methods for characterization of the mechanism of action of the toxin 
§ Competition analysis 
§ Flow cytometric assays: 
• Viability test: PI (propidium iodide) 
• Cell cycle analysis: DAPI 
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Results 
 
The study of mtDNA polymorphism among clinical Candida isolates 
 
The opportunistic human pathogen yeast C. parapsilosis has linear mitochondrial DNA 
with tandem repeats at the termini. Earlier study demonstrated the very stable RFLP 
pattern of the mtDNA within group I isolates of this species. Our survey on 23 Hungarian 
clinical isolates confirmed these results. 
 The occurrence and genetic variability of Candida albicans isolates in a 
Hungarian hospital were examined. Among the 103 Candida isolates, 44 (42.7%) proved 
to be C. albicans. The mitochondrial DNA profiles of the 44 clinical isolates of C. 
albicans were analysed. Total DNA purified from the strains were cut with restriction 
enzymes, which have plenty of recognition sites on nuclear DNA, and less on 
mitochondrial DNA (HaeIII digestion gave identical pattern, Hin6I gave two, while the 
digestion with HinfI resulted in four different patterns). The majority of the strains (23) 
were found to belong to the group labeled as type I. MtDNA types II and III include 11 
and 9 strains, respectively, while type IV was exhibited only by a single isolate. The 
variability was also studied using isolated mtDNAs of selected isolates. The restriction 
enzymes were selected on the basis of the frequency of their recognition sites. BglII and 
EcoRV have a numerous recognition sites on the mtDNA of C. albicans. Both of these 
enzymes gave distinct pattern on each type, supporting the results originated from total 
DNA digestion. Determining of the fragments’ size we observed that every type have an 
appr. 40 kb-genome size. 
The PvuII cleavage gave almost identical RFLP pattern in each type; only an 
appr. 50 bp difference could be detectable in the molecular weight of the smallest double 
PvuII fragments (position itself inside the repetitive region of the mtDNA). Primers were 
designed on this region, the fragment was amplified and sequenced. Results revealed a 55 
bp deletion in Type I., II. and IV. compared to Type III, in the upstream (intergenic) 
sequence of cox3 gene. This PvuII fragment contains the aforementioned EO3 region.  
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Mapping of the Candida albicans mtDNA types 
 
The physical maps of the mtDNAs of the four types (I: 10930, II: 9132, III: 5796, IV: 
17471) were generated by EcoRI-EcoRV. The EcoRI pattern of the mtDNAs seemed 
identical (6 fragments in each type), whereas the EcoRV pattern is distinctive. In silico, 
we generated the EcoRI-EcoRV map of C. albicans strain SC5314 found in the database. 
This strain is identical to Type III, hence we use it as a basic map. The differences in the 
organization are due to point mutations (e.g. GAT/ATC–GGT/ATC), which led to the 
distinctive EcoRV patterns. Partial genetic map was also constructed with the following 
hybridization probes: cox1, cox2, cox3, cob, nad1, nad2, nad4, nad5 and atp6. The 
hybridizations explored the same gene order in the four types, as in SC 5314 strain. 
 
Typing methods of Candida albicans isolates 
 
We could manage to group our clinical isolates into the types Miyakawa and co-workers 
established: no. 5796 isolate (Type III.) belongs to L, no. 9132 (Type II.) and no. 10930 
(Type I.) belongs to MII, while no. 17471 (Type IV.) is MI. Neither of the examined 
isolates represent type S. 
In order to establish a new typing method, we chose a region, which differ in the 
four types corresponding to the EcoRV sites. The chosen FZRV region is involved in the 
largest EcoRI fragment. We designed primers to this region (FZRV) to amplify it. The 
PCR product (1551 bp) was digested with EcoRV. Type I contains no EcoRV site within 
this region (1551 bp), Type II. carries two EcoRV sites (920bp, 403 bp, 228 bp), while 
Type III and Type IV possess the same one EcoRV site (1323 bp, 228 bp), but Type IV 
could be differentiated from Type III by BglII digestion. We examined the PCR-RFLP 
pattern of the FZRV region of several geographically distinct C. albicans isolates. The 
survey of PCR RFLP pattern of the region we chose to differentiate among clinical 
isolates is a good alternative epidemiological tool, beside the abovementioned EO3 
region analysis. 
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Karyotyping of clinical Candida albicans isolates 
 
The electrophoretic karyotypes of strains belonging to the different mtDNA types were 
analyzed. One additional chromosomal DNA band was detected in type II strains 
compared to the C. albicans 1006 strain. This band located between chromosomes 
number 3 and 4 (1.8 Mb and 1.7 Mb). Another well characterized C. albicans strain, WO-
1 also carries an extra chromosome compared to strain 1006, however, the size of that 
chromosome (1.65 Mb) is different from that observed in mtDNA type II isolates (The 
Candida albicans physical map site; http://albicansmap.ahc.umn.edu/). 
 
Analyzing of Candida maltosa mt genome on the level of nucleotide 
sequence 
 
The EcoRV-PstI restriction map of C. maltosa was generated, thereafter we carried out 
the sequencing of the whole mt genome. The size of the CBS 5611 mtDNA is 62949 base 
pairs and it is circular. It has the standard set of genes: atp6-8-9, cox1, cox2, cox3, cob, 
nad1-2-3-4-4L-5-6, rns, rnl and 26 tRNA. Three of the genes (cox1, cob and rnl) contain 
2-2 introns. The genome contains two repeat regions: one is on the direct strand (12859-
27237 nt); the other is on the complement strand (40937-55315 nt). 
 
Comparative analysis of mitochondrial introns of the species belonging 
to C. albicans clade 
 
The study of introns can be a tool to establish additional typing methods. One can take 
advantage of their presence or absence, furthermore of their differing size to design 
primers on the flanking exon regions, to generate species specific PCR products. Among 
the fourteen examined strains of the C. albicans clade (outgroup: D. hanseniaspora), only 
L. elongisporus proved to be intron-free. The number and the size of the introns are not in 
correlation with the whole mt genome size. Four genes, namely cox1, cob, rnl and nad5 
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contain introns, the majority of them are Group I. introns, Group II. intron appear only in 
four cases. 
 
The analysis of the spectra of Pichia anomala VKM Y-159 strain 
 
We tested the inhibitory effect on several yeast strains: some human pathogen yeast are 
inhibited (C. norvegica, C. tropicalis,C. guilliermondii, C. albicans, C. dubliniensis, C. 
glabrata, C. inconspicua, C. lypolitica and C. viswanathii), while others seemed to be 
resistant to the toxin. Therefore, the killer sensitivity pattern against this toxin can be a 
typing tool for discriminating several Candida species. 
 
Optimizing of the toxin production of Pichia anomala VKM Y-159 
strain 
 
One of the most important conditions for toxin production is the pH of the culture 
medium. As a rule, mycocins are most active at pH 4 - 5. The temperature range 15–20°C 
is optimal for incubation when assaying for mycocinogenic activity. We propose, that this 
strain has two different toxins, one (N toxin) has inhibitory effect only against C. 
norvegica, the other (GN toxin) has broader spectrum. Killer activity is only expressed 
under acidic conditions: the anti-C. norvegica N toxin has activity at pH values between 
2 and 6, while the GN toxin is active only on pH values 3 and 4. 
 
Characterization of the toxins produced by P. anomala VKM Y-159 
strain 
 
The toxins showed high stability up to 50°C. The toxins are stable against proteinase K 
and pronase E, suggesting that the toxins are either a small oligopeptide or a lipid. The 
lipidic nature can not been ruled out in the case of N toxin, which is smaller than 10 kDa. 
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The cytocidic or cytostatic effect was investigated on C. guilliermondii and C. 
norvegica by means of plate assays and flow cytometric measures. The toxins have cidic 
activity, and neither of them arrests the cell cycle. 
Several principal cell wall components can be involved in the binding of a killer 
toxin. In the case of GN toxin β-1,6 D-glucan (pustulane) is the receptor of the toxin, 
contrary to the most Pichia sp. toxin, while N toxin binds through general ionic 
interactions, especially via bivalent (e.g. Mg2+) cations.  
 
Protein analysis of the GN toxin 
 
To determine the size of the toxins, SDS PAGE method was used. The exact size of GN 
toxin was not yet defined, however it is either one of the detected proteins between 6-14 
kDa or it is a protein between 38-49 kDa. Chromatography experiments can not rule out 
the possible size of 62-98 kDa. The extracellular protein pattern of non-killer mutants 
does not differ from the pattern of the wild type. 
 
Analysing of the genetic background of toxins 
 
The genetic base of the killer toxin was examined. Neither plasmid nor viral elements 
was found using PFGE technique. Mycocin production is presumed to be determined by 
nuclear genes, as in most Pichia species. 
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Conclusions 
• The mtDNA polymorphism among C. albicans isolates was studied 
• Fourty-four clinical isolates were tested, four mtDNA types were established 
• Physical (EcoRI-EcoRV) and partial functional map of the types was generated 
• FZRV region was chosen, with distinctive EcoRV pattern - a good typing tool for 
differentiation of C. albicans strains, besides the existing EO3 typing. 
• Twenty-three clinical C. parapsilosis isolates were screened for mtDNA 
polymorphism all the isolates have the same mtDNA RFLP pattern 
• Sequencing of the whole mt genome of Candida maltosa CBS 5611 strain 
revealed a size of 62949 bp, and circular conformation. 
• The comparative analysis of mitochondrial intron content of the species belong to 
C. albicans clade was carried out. 
• We tested the spectra of the toxin produced by Pichia anomala VKM Y-159 
strain. 
• We propose, that this strain produces at least two kinds of toxin, one is active only 
against C. norvegica (N toxin), the other has a broader spectrum (GN toxin). 
• The toxins can be applied for biotyping of several Candida species 
• We optimized the killer toxin production of Pichia anomala VKM Y-159 strain 
• Both of the toxins are resistant to high temperature and protein degrading 
enzymes 
• The N toxin is lipid, while the GN toxin has proteinaceous nature 
• Both of the toxins have cidic effect, and they do not arrest the cell cycle. 
Presumably they make pores on the plasma membrane. 
• The specific cell wall receptor of GN toxin is ß-1,6 D-glucane, while the binding 
of N toxin based upon general ionic interactions. 
• The exact size of GN toxin is not yet determined. 
• No extrachromosomal element beside the mtDNA could be detected, so we can 
conclude that the killer phenotype is coded on the chromosome.  
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